CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

Lokman Hekim Tanrıverdi; Ahmet Sarıcı

doi:10.1016/s2152-2650(24)01271-0

Back

CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

Article 2024 en

Related publications

Article2024

Venetoclax Plus Ibrutinib As First-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

Lokman Hekim Tanrıverdi, Ahmet Sarıcı

Article2017

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib

Jan A. Burger, Kelvin W. Li, Michael J. Keating, Mariela Sivina, Ahmed M. Amer, Naveen Garg, Alessandra Ferrajoli, Xuelin Huang, Hagop Kantarjian, William G. Wierda, Susan O’Brien, Marc Hellerstein, Scott Turner, Claire Emson, Shih‐Shih Chen, Xiao‐Jie Yan, Dominik Wodarz, Nicholas Chiorazzi

Article2025

Intake of benzodiazepines in treatment naïve chronic lymphocytic leukemia patients is associate with a shorter time to first treatment

Tamar Tadmor, G. Lavie, Guy Melamed, Hilel Alapi, Lior Rokach

Leukemia & lymphoma/Leukemia and lymphoma

Article2024

Differential Cardiotoxicity of Ibrutinib Versus Chemoimmunotherapy in Chronic Lymphocytic Leukemia: A Population-Based Study

Abdulrahman Majrashi, Ying X. Gue, Alena Shantsila, Stella Williams, Professor Gregory Lip, Andrew R. Pettitt

Article2024

Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment

Tamar Tadmor, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon, Lior Rokach

Blood Advances

CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

Discussion(0)

Related publications

Venetoclax Plus Ibrutinib As First-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib

Intake of benzodiazepines in treatment naïve chronic lymphocytic leukemia patients is associate with a shorter time to first treatment

Differential Cardiotoxicity of Ibrutinib Versus Chemoimmunotherapy in Chronic Lymphocytic Leukemia: A Population-Based Study

Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment